niquitin mentol 2 mg
fertin pharma a/s - danemarca - nicotinum - guma mast. medicamentoasa - 2mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
niquitin mentol 4 mg
fertin pharma a/s - danemarca - nicotinum - guma mast. medicamentoasa - 4mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
niquitin fresh mint 2 mg
fertin pharma a/s - danemarca - nicotinum - guma mast. medicamentoasa - 2mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
niquitin fresh mint 4 mg
fertin pharma a/s - danemarca - nicotinum - guma mast. medicamentoasa - 4mg - med. pentru tratamentul dependentei de substante med. utilizate in tratamentul dependentei de nicotina
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - blocaj blocant - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
sugammadex mylan
mylan ireland limited - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex rompharm 100 mg/ml soluţie injectabilă
s.c. rompharm company s.r.l. - sugammadex sodium - soluţie injectabilă - 100 mg/ml